Biopharma calls on vendors to commit to ‘greener’ supply chain

CEOs from Roche, GSK, and AstraZeneca are among signatories of an open letter calling on suppliers to commit to climate and sustainability targets.

The healthcare sector contributes around 5% of global greenhouse gas emissions, half of which comes from supply chains, the letter claims before calling on biopharma partners to rapidly move towards a “greener, more efficient, and circular” process.

The letter – also signed by the CEOs of Big Pharma firms Novo Nordisk, Merck KGaA, and Sanofi, as well as contract manufacturer Samsung Biologics – urges suppliers to sign-up to a set of joint, minimum climate and sustainability targets, based around core commitments laid out by the same seven firms ahead of COP27 in November last year.

DepositPhotios/malpetr

They are:

The full letter can be found below.

This is the latest example of end-users demanding greener supply chains to help achieve their sustainability goals. In August last year, GlaxoSmithKline (GSK) launched a sustainability program calling on its network of over 160 suppliers to take action on sustainability commitments and make improvements on emissions, energy, heat, transport, waste, water and biodiversity.

Joint Ceo Letter Final 200723 by Dan Stanton on Scribd

This article has been changed to reflect one of the signatories was the CEO of Merck KGaA and not, as first written, Merck & Co.